Hafeez U - Search Results

1

Antibody-Drug Conjugates for Cancer Therapy.

Hafeez U, Parakh S, Gan HK, Scott AM. Hafeez U, et al. Molecules. 2020 Oct 16;25(20):4764. doi: 10.3390/molecules25204764. Molecules. 2020. PMID: 33081383 Free PMC article. Review.

2

Use of multicompartment compliance aids for elderly patients: patient viewpoints and hospital length of stay.

Brown SH, Hafeez U, Abdelhafiz AH. Brown SH, et al. Among authors: hafeez u. Postgrad Med. 2010 Jul;122(4):186-91. doi: 10.3810/pgm.2010.07.2185. Postgrad Med. 2010. PMID: 20675981

3

Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies.

Brastianos PK, Ippen FM, Hafeez U, Gan HK. Brastianos PK, et al. Among authors: hafeez u. Oncologist. 2018 Sep;23(9):1063-1075. doi: 10.1634/theoncologist.2017-0614. Epub 2018 Apr 27. Oncologist. 2018. PMID: 29703764 Free PMC article. Review.

4

Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases.

Hafeez U, Gan HK, Scott AM. Hafeez U, et al. Curr Opin Pharmacol. 2018 Aug;41:114-121. doi: 10.1016/j.coph.2018.05.010. Epub 2018 Jun 5. Curr Opin Pharmacol. 2018. PMID: 29883853 Review.

5

Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.

Hafeez U, Menon S, Nguyen B, Lum C, Gaughran G, Pranavan G, Cher L, Nowak AK, Gan HK, Parakh S. Hafeez U, et al. J Clin Neurosci. 2019 Oct;68:45-50. doi: 10.1016/j.jocn.2019.07.063. Epub 2019 Jul 29. J Clin Neurosci. 2019. PMID: 31371189

6

New insights into ErbB3 function and therapeutic targeting in cancer.

Hafeez U, Parslow AC, Gan HK, Scott AM. Hafeez U, et al. Expert Rev Anticancer Ther. 2020 Dec;20(12):1057-1074. doi: 10.1080/14737140.2020.1829485. Epub 2020 Oct 26. Expert Rev Anticancer Ther. 2020. PMID: 32981377 Review.

7

Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma.

Balasubramanian A, Gunjur A, Hafeez U, Menon S, Cher LM, Parakh S, Gan HK. Balasubramanian A, et al. Among authors: hafeez u. Neurooncol Adv. 2020 Dec 22;3(1):vdaa171. doi: 10.1093/noajnl/vdaa171. eCollection 2021 Jan-Dec. Neurooncol Adv. 2020. PMID: 33543145 Free PMC article. Review.

8

Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review.

Gunjur A, Balasubramanian A, Hafeez U, Menon S, Cher L, Parakh S, Gan HK. Gunjur A, et al. Among authors: hafeez u. J Neurooncol. 2022 Sep;159(3):539-549. doi: 10.1007/s11060-022-04092-7. Epub 2022 Aug 6. J Neurooncol. 2022. PMID: 35933567 Review.

9

Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review.

Gunjur A, Balasubramanian A, Hafeez U, Menon S, Cher L, Parakh S, Gan HK. Gunjur A, et al. Among authors: hafeez u. J Neurooncol. 2022 Sep;159(3):551. doi: 10.1007/s11060-022-04119-z. J Neurooncol. 2022. PMID: 35994157 No abstract available.

10

Antibody drug conjugates for glioblastoma: current progress towards clinical use.

Gan HK, Parakh S, Osellame LD, Cher L, Uccellini A, Hafeez U, Menon S, Scott AM. Gan HK, et al. Among authors: hafeez u. Expert Opin Biol Ther. 2023 Jul-Dec;23(11):1089-1102. doi: 10.1080/14712598.2023.2282729. Epub 2023 Dec 15. Expert Opin Biol Ther. 2023. PMID: 37955063 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters